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I read the paper by Kanat-Pektas et al [1] regarding the best
ﬁrst-line approach for cesarean scar pregnancy (CSP) with great in-
terest. In the ﬁrst systematic review focusing on the best treatment
modalities for CSP, it was concluded that hysteroscopy and laparo-
scopic hysterotomy appear as safe and efﬁcient surgical procedures
that can be adopted as primary treatment modalities for CSP; uter-
ine artery embolization (UAE) should be reserved for CSP with sig-
niﬁcant bleeding and/or a high suspicion index for arteriovenous
malformation; systemic methotrexate (MTX) and dilatation and
curettage (D&C) are not recommended as ﬁrst-line approaches
for CSP. However, to the best of our knowledge, the conclusion re-
mains to be discussed.
So far, more than 30 CSP treatment modalities have been pub-
lished, however the best approach for CSP is still under debate
[1,2]. A number of studies have indicated that systemic MTX and
D&C are not recommended as ﬁrst-line approaches for CSP, as these
procedures are associated with high complication and hysterec-
tomy rates [1]. As a result, it is suggested that an interventional
rather than a medical approach should be adopted in the manage-
ment of CSP [2,3].
There are many different kinds of interventional approaches
for CSP, involving UAE, hysteroscopic hysterotomy, laparoscopic
hysterotomy, and transvaginal hysterotomy [1e3]. The advantage
of hysterotomy lies in quicker recovery and a deﬁnite clinical ef-
fect because of immediate resection of the CSP lesion. In this re-
view, laparoscopic hysterotomy and hysteroscopy are
recommended as ﬁrst-line approaches for CSP, while transvaginal
hysterotomy is not on the list. It is also worth noting that the so-
called hysteroscopy involves hysteroscopic removal of gestational
tissue and hysteroscopic intragestational MTX injection. More sur-
prisingly, the authors do not introduce UAE as a primary ﬁrst-line
treatment modality for CSP due to its low success rate (18.3%) and
high complication rate. They suggest UAE should just be reserved
for CSP with signiﬁcant bleeding and/or a high suspicion index for
arteriovenous malformation. This opinion is obviously inconsis-
tent with previous researches, as most literatures reported that
UAE can be listed as a ﬁrst-line treatment modality for CSP [4,5].
In my opinion, the different conclusions in these studies may
be due to a number of effects. First, too many individual case re-
ports (64.9%, 126/194) were enrolled in this review, which mayhttp://dx.doi.org/10.1016/j.tjog.2016.07.005
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).enhance the risk of selection bias. Second, the efﬁcacy of the ther-
apeutics was evaluated by whether the patient needed a second-
ary treatment; if so, this approach was identiﬁed as treatment
failure. Under these criteria, although the hysterectomy rate of
some procedures was low, the failure rate of this procedure
may be high anyway. Actually, except hysterotomy, most of the
therapeutic regimens need to be combined. For example, UAE
in combination with D&C should be termed as one regimen and
the authors should not indicate the failure of UAE when it needs
a secondary treatment of D&C. Third, a high complication rate
should not be accessed as the failure of some treatment. There
are no standard criteria for the deﬁnition of each approach's
complication, for example, as reported, the complication rate of
UAE for CSP ﬂuctuates from 6.67% to 80% [2,4]. However, apart
from the serious complications such as hysterectomy and hemor-
rhage, other complications are acceptable in the treatment. Last,
but not least, at the beginning of the paper, the authors chose the
most frequently adopted CSP therapeutic regimens for following
evaluation. Obviously, the most adopted treatment modalities be-
ing not the best ones, not to mention to be the best ﬁrst-line ap-
proaches. In this way, they will deﬁnitely omit some new
approaches with good efﬁcacy, because the option of CSP treat-
ment modalities is closely related with the recognition and pro-
motion of medical care. In the past, systemic MTX and D&C
were preferred by gynecologists, however, nowadays more and
more individuals are willing to choose UAE and hysterotomy.
For example, transvaginal hysterotomy turns out to be a good
novel approach for CSP [3].
Recently, Birch Petersen et al [2] have done some similar
research. With strict screening criteria, 2037 patients with CSP in
52 selected studies from 1492 literatures (until June 2015) were
involved in their analysis. After data extraction and statistical anal-
ysis, the therapeutic regimens for CSP were classiﬁed into 14 cate-
gories. Combining study quality, level of evidence, efﬁcacy, and
safety, they recommended ﬁve approaches for treating CSP, which
were transvaginal hysterotomy, laparoscopic hysterotomy, UAE in
combination with D&C and hysteroscopy, UAE in combination
with D&C, and hysteroscopic hysterotomy. The success rates were
99.2%, 97.1%, 95.4%, 93.6%, and 83.2%, respectively, while the hyster-
ectomy rates were 0.85% (1/118), 0.0% (0/69), 1.16% (1/85), 2.03% (6/
295), and 1.05% (1/95). Therefore, the authors thought that the pre-
sent evidence supported that an interventional rather than medicaly Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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safe and efﬁcient clinical approach for CSP is yet to be determined,
but above ﬁve approaches depending on availability, severity of pa-
tient symptoms, and surgical skills are recommended.
The characteristic of this study is that they came to the conclu-
sion after systemic comparison of each approach instead of
comparing the most common regimens, which is of greater clinical
value. This review indicated that two of the ﬁve recommended ap-
proaches are UAE related, the results of which are completely
different from the research by Kanat-Pektas et al [1]. This may
possibly be because Birch Petersen et al [2] termed the combination
therapy of UAE and D&C or other procedure as one approach for
CSP, but not as treatment failure. Moreover, transvaginal hysterot-
omy stands out in all ﬁve recommended approaches with a higher
success rate.
Although the most safe and efﬁcient clinical approach for CSP is
yet to be determined, its ﬁrst-line approach is an interventional
rather than a medical approach. UAE in combination with D&C,
transvaginal hysterotomy, laparoscopic hysterotomy, and hystero-
scopic hysterotomy could all be recommended as primarily ﬁrst-
line treatment approaches at present.
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